AMGEN, INC. for AMGEN INC

Taxation/Internal Revenue Code TAX

Issues related to corporate and international tax, including regarding Public Law 115-97, Tax Cuts and Jobs Act Issues related to Puerto Rico FY 2022 Budget Request by President Biden The American Jobs Plan H.R. 7527, Medical Manufacturing, Economic Development, and Sustainability Act of 2020 H.R. 6930, Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020 Proposed Rule, Guidance Related to the Foreign Tax Credit, Clarification of Foreign-Derived Intangible Income Issues related to OECD negotiations on the taxation of global income

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6930 (117th), H.R. 7527 (117th)

Copyright/Patent/Trademark CPT

Issues related to drug patents and exclusivities, no specific bill Patent eligibility reform, no specific bill FTC related issues, no specific bill Issues related to World Trade Organization IP waiver, no specific bill

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Executive Office of the President (EOP)

Health Issues HCR

Biosimilars reimbursement issues, no specific bill H.R. 3, Prescription drug pricing issues FDA issues, no specific bill Supply Chain Issues, no specific bill Patent thickets/product hopping, no specific bill Mergers/acquisitions, no specific bill

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; Executive Office of the President (EOP)

Bills named: H.R. 3 (117th)

Medicare/Medicaid MMM

S. 99 The Medicare Drug Price Negotiation Act H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act Issues related to Drug Pricing Issues related to clinical trial diversity S. 1943 and H.R. 3517, Issues related to DXA, osteoporosis Issues related to international reference pricing Issues related to the 340B program, no specific bill Reimbursement for biologics/biosimilars Issues related to Medicare Part D redesign Issues related to patient affordability issues, including copay cards, copay accumulators, National Benefit Payment Parameters Medicare End Stage Renal Disease Prospective Payment System (ESRD PPS) Proposed Rule (bundled payment for calcimimetics) Patent thickets/product hopping, no specific bill Mergers/acquisitions, no specific bill Labor-HHS Appropriations

Contacted: Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 99 (117th), H.R. 3517 (117th), H.R. 3 (117th), S. 1943 (117th)